High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran

Hepatology Research

Volumn 33, Issue 4, 2005, Pages 292-297

  Hashemi, Mohammad ^a   Alavian, Seyed Moayed ^b   Ghavami, Saeid ^a,f   de Serres, Frederick J ^c   Salehi, Masoud ^a   Doroudi, Taher ^d   Fard, Amir Hossain Mahagheghi ^a   Mehrabifar, Hamid ^a   Milani, Behzad ^e   Shahri, Seyed Javad Saeidi ^b  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d Tehran Heart Center   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alpha 1 antitrypsin; Chronic active hepatitis; Cirrhosis; Viral hepatitis B

Indexed keywords

ALPHA 1 ANTITRYPSIN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; IRAN; LABORATORY TEST; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPIC VARIATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; VIRUS CARRIER;

EID: 29144523100     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.09.035     Document Type: Article

References (40)

1. S.M. Alavian F. Nematizadeh Occult HBV infection in patients with serological markers of past HBV infection Am J Gastroenterol 98 2003 937-938
2. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 2004 97-107
3. L.S. Marsano Hepatitis Prim Care 30 2003 81-107
4. M.C. Yu J.M. Yuan S. Govindarajan et al. Epidemiology of hepatocellular carcinoma Can J Gastroenterol 14 2000 703-709
5. F.J. Mahoney Update on diagnosis, management, and prevention of hepatitis B virus infection Clin Microbiol Rev 12 1999 351-366
6. A.S. Lok E.J. Heathcote J.H. Hoofnagle Management of hepatitis B: 2000 - summary of a workshop Gastroenterology 120 2001 1828-1853
7. F.J. de Serres Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed Environ Health Perspect 111 2003 1851-1854
8. S. Ghavami M. Hashemi H.A. Shahriari et al. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran Clin Biochem 38 2005 425-432
9. R. Huber R.W. Carrell Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins Biochemistry 28 1989 8951-8966
10. D.H. Perlmutter Liver injury in alpha1-antitrypsin deficiency: An aggregated protein induces mitochondrial injury J Clin Invest 110 2002 1579-1583
11. D. Perlmutter A. Arias The liver: Biology and pathobiology 2001 Raven Press New York 699-719
12. J. Teckman D. Qu D. Perlmutter Molecular pathogenesis of liver disease in α1-antitrypsin deficiency Hepatology 24 1996 1504-1516
13. R. Crystal Alpha1-antitrypsin deficiency, emphysema and liver disease: genetic basis and strategies for therapy J Clin Invest 95 1990 1343-1352
14. F.J. de Serres I. Blanco E. Fernandez-Bustillo Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain Clin Genet 63 2003 490-509
15. A. Janoff Elastases and emphysema: Current assessment of the protease-antiprotease hypothesis Am Rev Respir Dis 132 1985 417-433
16. T. Propst A. Propst O. Dietz et al. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1 antitrypsin deficiency and chronic liver disease Ann Intern Med 117 1992 641-645
17. T. Propst A. Propst O. Dietz et al. Prevalence of hepatocellular carcinoma in alpha 1 antitrypsin deficiency J Hepatol 21 1994 1006-1011
18. J.O. Jeppsson B. Franzen Typing of genetic variants of alpha 1-antitrypsin by electrofocusing Clin Chem 28 1982 219-225
19. Y. Kishimoto S. Yamada C. Hirayama An association between alpha 1 antitrypsin and chronic liver disease Hum Genet 84 1990 132-136
20. R. Aschauer F. Holzknecht S. Platzer Endogenous inhibitors of fibrinolytic activity in liver cirrhosis Klin Wochenschr 51 1973 1170-1172
21. A.A. Dietz H.M. Rubinstein L.K. Hodges Measurement of alpha 1 antitrypsin in serum, by immunodiffusion and enzymatic assay Clin Chem 20 1974 396-399
22. M. Fagerhol D. Cox The Pi polymorphism: Genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin Adv Genet 11 1981 1-62
23. F. Kueppers E.R. Dickson W.H. Summerskill Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis Mayo Clin Proc 51 1976 286-288
24. B. Miszczuk-Jamska W. Pajdak H. Barylak et al. Serum trypsin inhibitory activity and alpha-1-antitrypsin level in liver diseases Folia Histochem Cytobiol 24 1986 173-177
25. G. Theodoropoulos A. Archimandritis A. Tsomi et al. Serum trypsin inhibitory capacity and alpha 1-antitrypsin levels in liver cirrhosis and hepatoma Acta Hepatogastroenterol (Stuttg) 26 1979 195-197
26. D.H. Perlmutter Liver disease associated with alpha 1-antitrypsin deficiency Prog Liver Dis 11 1993 139-165
27. D. Qu J.H. Teckman D.H. Perlmutter Review: Alpha 1-antitrypsin deficiency associated liver disease J Gastroenterol Hepatol 12 1997 404-416
28. J. Hodges G. Millward-Sadler C. Barbatis et al. Heterozygous MZ alpha 1 antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis N Engl J Med 304 1981 557-560
29. R.L. Fisher L. Taylor S. Sherlock Alpha-1-antitrypsin deficiency in liver disease: The extent of the problem Gastroenterology 71 1976 646-651
30. H.L. Sharp R. Mathis W. Krivit et al. The liver in noncirrhotic-1-antitrypsin deficiency J Lab Clin Med 78 1971 1012-1013
31. H.L. Sharp Alpha-1-antitrypsin: An ignored protein in understanding liver disease Semin Liver Dis 2 1982 314-328
32. M.C. Jung G.R. Pape Immunology of hepatitis B infection Lancet Infect Dis 2 2002 43-50
33. K. Kakimi L.G. Guidotti Y. Koezuka et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo J Exp Med 192 2000 921-930
34. E.W. Ades A. Hinson C. Chapuis-Cellier et al. Modulation of the immune response by plasma protease inhibitors. I. Alpha 2-macroglobulin and alpha 1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity Scand J Immunol 15 1982 109-113
35. S.N. Breit E. Luckhurst R. Penny The effect of alpha 1 antitrypsin on the proliferative response of human peripheral blood lymphocytes J Immunol 130 1983 681-686
36. S.N. Breit R. Penny The role of alpha 1 protease inhibitor (alpha 1 antitrypsin) in the regulation of immunologic and inflammatory reactions Aust N Z J Med 10 1980 449-453
37. S.N. Breit J.P. Robinson E. Luckhurst et al. Immunoregulation by alpha 1 antitrypsin J Clin Lab Immunol 7 1982 127-131
38. S.N. Breit J.P. Robinson R. Penny The effect of alpha 1 antitrypsin on phagocyte function J Clin Lab Immunol 10 1983 147-149
39. D. Hudig D. Redelman L.L. Minning The requirement for proteinase activity for human lymphocyte-mediated natural cytotoxicity (NK): evidence that the proteinase is serine dependent and has aromatic amino acid specificity of cleavage J Immunol 133 1984 2647-2654
40. S. Eriksson J. Carlson R. Velez Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency N Engl J Med 314 1986 736-739